Consistent with the upregulation of the anti-apoptotic proteins, Bcl-2 and p53, which are frequently suppressed, inhibitors of apoptosis proteins (IAPs) are usually overexpressed in multiple cancers conveying resistance to apoptosis and worsening disease [52,53]. The gene discussed is BCL2; the disease is cancer.